Lv4
598 积分 2025-11-21 加入
Targeting Interleukin-7 Signalling in Ulcerative Colitis: Rationale and Emerging Clinical Evidence
14天前
已完结
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
21天前
已完结
Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease
1个月前
已完结
Advancements in therapeutic strategies and drug development for inflammatory bowel diseases
3个月前
已完结
Lysosome-targeting chimeras enable targeted protein degradation
5个月前
已关闭
Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis
6个月前
已完结
Establishing a flow cytometry‐based tissue receptor occupancy assay for an anti‐oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease
6个月前
已完结
Differential therapeutic implications of the OSM-OSMR signaling pathway in cancer and inflammatory diseases
6个月前
已完结
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters
7个月前
已完结
Soluble oncostatin M receptor (sOSMR): A potential biomarker in systemic sclerosis diagnosis
7个月前
已完结
皖公网安备34019202002308
